A Placebo-controlled, Double-blind, Randomized, Cross Over Pilot Study of the Efficacy and Tolerability of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 28 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 1 Jan 2018.
- 18 Aug 2017 Planned initiation date changed from 1 May 2017 to 1 Oct 2017.
- 04 May 2017 New trial record